Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-3) and related Prospectus of Verve Therapeutics, Inc. for the registration of $400,000,000 of debt securities, common stock, preferred stock, units and warrants, and to the incorporation by reference therein of our report dated March 14, 2022, with respect to the consolidated financial statements of Verve Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ Ernst and Young LLP
Boston, Massachusetts
July 1, 2022
